Recovery & Repair

Recovery and repair peptides are among the most extensively researched compounds in preclinical science, with multiple mechanisms identified that support soft tissue healing, connective tissue regeneration, and vascular repair. This category is characterized by peptides that interact with the body's endogenous healing cascade - particularly angiogenesis, extracellular matrix remodeling, and cellular migration - rather than suppressing inflammation pharmacologically.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has demonstrated a remarkably broad healing profile across dozens of animal studies, acting through the nitric oxide (NO) system, VEGF-driven angiogenesis, and modulation of the COX-2 pathway. TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring peptide that plays a central role in actin polymerization and cellular migration - processes fundamental to wound closure and tissue repair. TB4-Frag is a shorter derivative retaining key activity with altered pharmacokinetics. KPV, a tripeptide derived from alpha-MSH, contributes anti-inflammatory activity through melanocortin receptor signaling.

A key characteristic of this peptide class is systemic activity - research suggests these compounds may exert repair effects at sites distant from their administration route, a property with significant implications for understanding their mechanism. Stability profiles, reconstitution, and storage conditions are active areas of research given their importance for reliable experimental outcomes.